Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Average Rating of "Moderate Buy" by Brokerages
Cartesian Therapeutics, Inc. (NASDAQ:RNAC - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five research firms that are currently covering the firm, Marketbeat.com...